$9 million grant for prostate cancer research

Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.

The clinical trial is part of a $9 million grant from the National Cancer Institute (NCI) awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.

"As part of this research grant we have had encouraging results involving two smaller clinical studies," says Svend Freytag, Ph.D., division head of Research, Radiation Oncology, Henry Ford Hospital.

Dr. Freytag, along with Benjamin Movsas, M.D., chair of Radiation Oncology and Hans Stricker, M.D., vice chair of Urology at Henry Ford Hospital are the study's key researchers.

Because of the results from the previous trials, NCI approved a phase III trial involving 280 prostate cancer patients over a three-year period. A phase III trial is the final stage in a study to determine if the treatment being studied should become the standard treatment.

Currently radiation therapy (without the gene therapy) or surgical removal of the prostate is the standard treatment for patients with localized prostate cancer, with similar cure rates. Prostate Cancer is the second leading cause of cancer death for men according to the American Cancer Society.

"When you consider that across the world most trials involving gene therapy are in very early stages of development involving research in test tubes, the fact that Henry Ford Hospital is now embarking on a major phase III clinical trial to test this as a new standard treatment, is a testament to the world class innovative research taking place right here," says Dr. Movsas, principal investigator of the study. "To my knowledge, this is the only place in the world where such a gene therapy study is available for this group of patients," he adds.

(Published at Health News Track on February 8, 2008 - 333 days ago)

Prostate cancer article/news source:

Henry Ford Health System - read other health news articles from Henry Ford Health System and health news articles from USA.

Prostate cancer - related articles/news stories:

- Prostate cancer family history has no impact on treatment
- Income linked to prostate cancer grade
- Men with wives more likely to be screened for prostate cancer
- PSA screening awareness needed among high-risk groups
- Prostate cancer screening for men over 75 not required
- Broccoli rich diet prevents prostate cancer
- Type 2 diabetes genes associated with prostate cancer
- 7 new prostate cancer genetic risk factors identified
- Simple urine test detecting prostate cancer accurately


»» Adverse reactions linked to Botox use, warns FDA
«« In Vitro Fertilization Research Centre in AIIMS, India

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
We comply with the HONcode principles for trustworthy health information, verify here.
www.healthnewstrack.com - About us, Editorial team, Advertising, Jobs, Links, Privacy policy, Disclaimer, Feedback,
Site map, List health news, Health news organizations, Health news world, Accessibility, Glossary, Testimonials, Blog
Mobile/PDA Submit press release
© 2007-2008 HealthNewstrack.com
Track Health News Daily
1.62